Modulation of 5-IODO-2′-deoxyuridine metabolism and cytotoxicity in human bladder cancer cells by fluoropyrimidines

Al B. Benson, Donald L. Trump, Kenneth B. Cummings, Paul H. Fischer*

*Corresponding author for this work

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Iododeoxyuridine (IdUrd) potentiated the lethal but not the growth inhibitory properties of fluorouracil (FUra) and fluorodeoxyuridine (FdUrd) in human bladder cancer cells (T24). The rate of incorporation of IdUrd into DNA was enhanced by both fluoropyrimidines, but to a significantly greater extent by FdUrd. Both inhibition of iododeoxyridylate dehalogenation and the depletion of thymidine triphosphate pools contributed to the increased incorporation rate. Inhibition of dehalogenation accounted for 67% of the observed stimulation in the case of FUra, but only 37% of the increase produced by FdUrd. The depletion of dTTP pools, both in the presence and absence of IdUrd, was greater after FdUrd than FUra exposure. The observed increase in the rate of incorporation of IdUrd appears to account for the enhanced toxicity seen with FdUrd, but other factors may be involved in the case of FUra. Since FUra and IdUrd appear to be mutually potentiating and do not share a dependence on thymidine kinase activity, this drug combination warrants further investigation.

Original languageEnglish (US)
Pages (from-to)3925-3931
Number of pages7
JournalBiochemical Pharmacology
Volume34
Issue number21
DOIs
StatePublished - Nov 1 1985

Fingerprint

Floxuridine
Idoxuridine
Deoxyuridine
Cytotoxicity
Urinary Bladder Neoplasms
Metabolism
Fluorouracil
Cells
Modulation
Dehalogenation
Thymidine Kinase
Drug Combinations
Toxicity
DNA
Growth

ASJC Scopus subject areas

  • Biochemistry
  • Pharmacology

Cite this

Benson, Al B. ; Trump, Donald L. ; Cummings, Kenneth B. ; Fischer, Paul H. / Modulation of 5-IODO-2′-deoxyuridine metabolism and cytotoxicity in human bladder cancer cells by fluoropyrimidines. In: Biochemical Pharmacology. 1985 ; Vol. 34, No. 21. pp. 3925-3931.
@article{87b140e4b47f42cd89302c69eee50c84,
title = "Modulation of 5-IODO-2′-deoxyuridine metabolism and cytotoxicity in human bladder cancer cells by fluoropyrimidines",
abstract = "Iododeoxyuridine (IdUrd) potentiated the lethal but not the growth inhibitory properties of fluorouracil (FUra) and fluorodeoxyuridine (FdUrd) in human bladder cancer cells (T24). The rate of incorporation of IdUrd into DNA was enhanced by both fluoropyrimidines, but to a significantly greater extent by FdUrd. Both inhibition of iododeoxyridylate dehalogenation and the depletion of thymidine triphosphate pools contributed to the increased incorporation rate. Inhibition of dehalogenation accounted for 67{\%} of the observed stimulation in the case of FUra, but only 37{\%} of the increase produced by FdUrd. The depletion of dTTP pools, both in the presence and absence of IdUrd, was greater after FdUrd than FUra exposure. The observed increase in the rate of incorporation of IdUrd appears to account for the enhanced toxicity seen with FdUrd, but other factors may be involved in the case of FUra. Since FUra and IdUrd appear to be mutually potentiating and do not share a dependence on thymidine kinase activity, this drug combination warrants further investigation.",
author = "Benson, {Al B.} and Trump, {Donald L.} and Cummings, {Kenneth B.} and Fischer, {Paul H.}",
year = "1985",
month = "11",
day = "1",
doi = "10.1016/0006-2952(85)90446-0",
language = "English (US)",
volume = "34",
pages = "3925--3931",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "21",

}

Modulation of 5-IODO-2′-deoxyuridine metabolism and cytotoxicity in human bladder cancer cells by fluoropyrimidines. / Benson, Al B.; Trump, Donald L.; Cummings, Kenneth B.; Fischer, Paul H.

In: Biochemical Pharmacology, Vol. 34, No. 21, 01.11.1985, p. 3925-3931.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Modulation of 5-IODO-2′-deoxyuridine metabolism and cytotoxicity in human bladder cancer cells by fluoropyrimidines

AU - Benson, Al B.

AU - Trump, Donald L.

AU - Cummings, Kenneth B.

AU - Fischer, Paul H.

PY - 1985/11/1

Y1 - 1985/11/1

N2 - Iododeoxyuridine (IdUrd) potentiated the lethal but not the growth inhibitory properties of fluorouracil (FUra) and fluorodeoxyuridine (FdUrd) in human bladder cancer cells (T24). The rate of incorporation of IdUrd into DNA was enhanced by both fluoropyrimidines, but to a significantly greater extent by FdUrd. Both inhibition of iododeoxyridylate dehalogenation and the depletion of thymidine triphosphate pools contributed to the increased incorporation rate. Inhibition of dehalogenation accounted for 67% of the observed stimulation in the case of FUra, but only 37% of the increase produced by FdUrd. The depletion of dTTP pools, both in the presence and absence of IdUrd, was greater after FdUrd than FUra exposure. The observed increase in the rate of incorporation of IdUrd appears to account for the enhanced toxicity seen with FdUrd, but other factors may be involved in the case of FUra. Since FUra and IdUrd appear to be mutually potentiating and do not share a dependence on thymidine kinase activity, this drug combination warrants further investigation.

AB - Iododeoxyuridine (IdUrd) potentiated the lethal but not the growth inhibitory properties of fluorouracil (FUra) and fluorodeoxyuridine (FdUrd) in human bladder cancer cells (T24). The rate of incorporation of IdUrd into DNA was enhanced by both fluoropyrimidines, but to a significantly greater extent by FdUrd. Both inhibition of iododeoxyridylate dehalogenation and the depletion of thymidine triphosphate pools contributed to the increased incorporation rate. Inhibition of dehalogenation accounted for 67% of the observed stimulation in the case of FUra, but only 37% of the increase produced by FdUrd. The depletion of dTTP pools, both in the presence and absence of IdUrd, was greater after FdUrd than FUra exposure. The observed increase in the rate of incorporation of IdUrd appears to account for the enhanced toxicity seen with FdUrd, but other factors may be involved in the case of FUra. Since FUra and IdUrd appear to be mutually potentiating and do not share a dependence on thymidine kinase activity, this drug combination warrants further investigation.

UR - http://www.scopus.com/inward/record.url?scp=0022354442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022354442&partnerID=8YFLogxK

U2 - 10.1016/0006-2952(85)90446-0

DO - 10.1016/0006-2952(85)90446-0

M3 - Article

C2 - 2933042

AN - SCOPUS:0022354442

VL - 34

SP - 3925

EP - 3931

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 21

ER -